{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:30:02Z","timestamp":1792801802408,"version":"4.5.0"},"reference-count":109,"publisher":"Wiley","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EFS2","EFSA Journal"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.2903\/j.efsa.2024.8747","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T09:18:51Z","timestamp":1715764731000},"source":"Crossref","is-referenced-by-count":6,"title":["Flavouring Group Evaluation 413 (FGE.413): Naringenin"],"prefix":"10.2903","volume":"22","author":[{"name":"EFSA Panel on Food Additives and Flavourings (FAF)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged","family":"Younes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Aquilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Degen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl\u2010Heinz","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Frutos\u00a0Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Gundert\u2010Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"G\u00fcrtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Hus\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Manco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Moldeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Passamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ine","family":"Waalkens\u2010Berendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romualdo","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bolognesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Cordelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"N\u00f8rby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Carf\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borana","family":"Dino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Mech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Multari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Mennes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.2903\/j.efsa.2024.8747_ref1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/10715760400017293","article-title":"The differential tissue distribution of the citrus flavanone Naringenin following gastric instillation","volume":"38","author":"Abd El Mohsen","year":"2004","journal-title":"Free Radical Research"},{"issue":"1","key":"10.2903\/j.efsa.2024.8747_ref2","first-page":"43","article-title":"Biliary metabolites of hesperetin in rats","volume":"47","author":"Abe","year":"1993","journal-title":"Traditional Chinese Medicine Research Lab"},{"key":"10.2903\/j.efsa.2024.8747_ref3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/mnfr.201500202","article-title":"Gastrointestinal absorption and metabolism of hesperetin\u20107\u2010O\u2010rutinoside and hesperetin\u20107\u2010O\u2010glucoside in healthy humans","volume":"59","author":"Actis\u2010Goretta","year":"2015","journal-title":"Molecular Nutrition & Food Research"},{"issue":"23","key":"10.2903\/j.efsa.2024.8747_ref4","first-page":"1","article-title":"Naringenin alters the pharmacokinetics of ranolazine in part through the inhibition of cytochrome P450 (3A4) and P\u2010glycoprotein","volume":"9","author":"Alotaibi","year":"2023","journal-title":"Future Journal of Pharmaceutical Sciences"},{"key":"10.2903\/j.efsa.2024.8747_ref5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jsbmb.2010.04.018","article-title":"Activation of transgenic estrogen receptor\u2010beta by selected phytoestrogens in a stably transduced rat serotonergic cell line","volume":"120","author":"Amer","year":"2010","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"12","key":"10.2903\/j.efsa.2024.8747_ref6","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/mnfr.201600315","article-title":"Urinary excretion of citrus flavanones and their major catabolites after consumption of fresh oranges and pasteurized orange juice: A randomized cross\u2010over study","volume":"60","author":"Aschoff","year":"2016","journal-title":"Molecular Nutrition & Food Research"},{"issue":"4","key":"10.2903\/j.efsa.2024.8747_ref7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1503\/cmaj.120951","article-title":"Grapefruit\u2010medication interactions: Forbidden fruit or avoidable consequences?","volume":"185","author":"Bailey","year":"2013","journal-title":"Canadian Medical Association Journal"},{"issue":"5","key":"10.2903\/j.efsa.2024.8747_ref8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1067\/mcp.2000.110774","article-title":"Grapefruit\u2010felodipine interaction: Effect of unprocessed fruit and probable active ingredients","volume":"68","author":"Bailey","year":"2000","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.2903\/j.efsa.2024.8747_ref9","unstructured":"Bhagwat, S., Haytowitz, D. B., & Holden, J. M. (2014). USDA database for the flavonoid content of selected foods, release 3.1. U.S. Department of Agriculture and Agricultural Research. Nutrient Data Laboratory Home Page. http:\/\/www.ars.usda.gov\/nutrientdata\/flav"},{"key":"10.2903\/j.efsa.2024.8747_ref10","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1002\/jssc.200800730","article-title":"Fast analysis of prominent flavonoids in tomato using a monolithic column and isocratic HPLC","volume":"32","author":"Biesaga","year":"2009","journal-title":"Journal of Separation Science"},{"issue":"1","key":"10.2903\/j.efsa.2024.8747_ref11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9258(18)70592-9","article-title":"Urinary metabolites of caffeic and chlorogenic acids","volume":"229","author":"Booth","year":"1957","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.2903\/j.efsa.2024.8747_ref12","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00204-018-2186-z","article-title":"Human\u2010relevant potency threshold (HRPT) for ER\u03b1 agonism","volume":"92","author":"Borgert","year":"2018","journal-title":"Archives of Toxicology"},{"key":"10.2903\/j.efsa.2024.8747_ref13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jn\/132.4.658","article-title":"Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor","volume":"132","author":"Branham","year":"2002","journal-title":"The Journal of Nutrition"},{"key":"10.2903\/j.efsa.2024.8747_ref14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1742-7843.2004.pto_940106.x","article-title":"The citrus\u2010derived flavonoid naringenin exerts uterotrophic effects in female mice at human relevant doses","volume":"94","author":"Breinholt","year":"2004","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.2903\/j.efsa.2024.8747_ref15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-1218(79)90083-1","article-title":"Mutagenicity of plant flavonols in the salmonella\/mammalian microsome test: Activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources","volume":"66","author":"Brown","year":"1979","journal-title":"Mutation Research"},{"key":"10.2903\/j.efsa.2024.8747_ref16","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/jn\/132.11.3349","article-title":"Naringenin from cooked tomato paste is bioavailable in men","volume":"132","author":"Bugianesi","year":"2002","journal-title":"The Journal of Nutrition"},{"issue":"21","key":"10.2903\/j.efsa.2024.8747_ref17","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1021\/jf0346861","article-title":"Influence of organic versus conventional agricultural practice on the antioxidant microconstituent content of tomatoes and derived purees; consequences on antioxidant plasma status in humans","volume":"52","author":"Caris\u2010Veyrat","year":"2004","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.2903\/j.efsa.2024.8747_ref18","first-page":"40","article-title":"GRAS 27 flavoring substances [FEMA expert panel]","volume":"69","author":"Cohen","year":"2015","journal-title":"Food Technology"},{"key":"10.2903\/j.efsa.2024.8747_ref19","unstructured":"Cohen, S. M., Fukushima, S., Goodermam, N. J., Hecht, S. S., Marnett, L. J., Rietjens, I. M. C. M., & Smith, R. L. (2015b). GRAS 27 Flavoring Substances (List of substances, Accompanying Use Level Tables and Supplementary Information). Flavor & Extract Manufacturers Association (FEMA), Expert Panel, Washington, DC."},{"key":"10.2903\/j.efsa.2024.8747_ref20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10408398109527317","article-title":"The constituents of tomato fruit\u2010the influence of environment, nutrition, and genotype","volume":"15","author":"Davies","year":"1981","journal-title":"CRC Critical Reviews in Food Science and Nutrition"},{"issue":"1","key":"10.2903\/j.efsa.2024.8747_ref21","first-page":"218","article-title":"Proposed template to be used in drafting scientific opinion on flavouring substances (explanatory notes for guidance included)","volume":"10","author":"EFSA (European Food Safety Authority)","year":"2012","journal-title":"EFSA Journal"},{"key":"10.2903\/j.efsa.2024.8747_ref22","doi-asserted-by":"crossref","unstructured":"EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids) . (2010a). Guidance on the data required for the risk assessment of flavourings to be used in or on foods. EFSA Journal, 8(6), 1623. https:\/\/doi.org\/10.2093\/j.efsa.2010.1623","DOI":"10.2903\/j.efsa.2010.1623"},{"key":"10.2903\/j.efsa.2024.8747_ref23","doi-asserted-by":"crossref","unstructured":"EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids) . (2010b). Scientific opinion on Flavouring group evaluation 32 (FGE.32): Flavonoids (flavanones and dihydrochalcones) from chemical groups 25 and 30. EFSA Journal, 8(9), 1065. https:\/\/doi.org\/10.2903\/j.efsa.2010.1065","DOI":"10.2903\/j.efsa.2010.1065"},{"key":"10.2903\/j.efsa.2024.8747_ref24","doi-asserted-by":"crossref","unstructured":"EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids) . (2017). Scientific opinion of Flavouring group evaluation 410 (FGE.410): 4\u2032,5,7\u2010trihydroxyflavanone from chemical group 25 (phenol derivatives containing ring\u2010alkyl, ring\u2010alkoxy, and side\u2010chains with an oxygenated functional group). EFSA Journal, 15(11), 5011. https:\/\/doi.org\/10.2903\/j.efsa.2017.5011","DOI":"10.2903\/j.efsa.2017.5011"},{"key":"10.2903\/j.efsa.2024.8747_ref25","doi-asserted-by":"crossref","unstructured":"EFSA FAF Panel (EFSA Panel on Food Additives and Flavourings) . (2022). Scientific guidance on the data required for the risk assessment of flavourings to be used in or on foods. EFSA Journal, 20(12), 7673. https:\/\/doi.org\/10.2903\/j.efsa.2022.7673","DOI":"10.2903\/j.efsa.2022.7673"},{"key":"10.2903\/j.efsa.2024.8747_ref26","doi-asserted-by":"crossref","unstructured":"EFSA Scientific Committee . (2009). Guidance of the scientific committee on transparency in the scientific aspects of risk assessments carried out by EFSA. Part 2: General principles. EFSA Journal, 7(7), 1051. https:\/\/doi.org\/10.2903\/j.efsa.2009.1051","DOI":"10.2903\/j.efsa.2009.1051"},{"key":"10.2903\/j.efsa.2024.8747_ref27","doi-asserted-by":"crossref","unstructured":"EFSA Scientific Committee . (2011). Scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment. EFSA Journal, 9(9), 2379. https:\/\/doi.org\/10.2903\/j.efsa.2011.2379","DOI":"10.2903\/j.efsa.2011.2379"},{"key":"10.2903\/j.efsa.2024.8747_ref28","doi-asserted-by":"crossref","unstructured":"EFSA Scientific Committee . (2021). Guidance on technical requirements for regulated food and feed product applications to establish the presence of small particles including nanoparticles. EFSA Journal, 19(8), 6769. https:\/\/doi.org\/10.2903\/j.efsa.2021.6769","DOI":"10.2903\/j.efsa.2021.6769"},{"key":"10.2903\/j.efsa.2024.8747_ref29","unstructured":"EMA (European Medicines Agency) . (2012). Guideline on the investigation of drug interactions. https:\/\/www.ema.europa.eu\/en\/investigation\u2010drug\u2010interactions\u2010scientific\u2010guideline"},{"issue":"2","key":"10.2903\/j.efsa.2024.8747_ref30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jn\/131.2.235","article-title":"Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice","volume":"131","author":"Erlund","year":"2001","journal-title":"The Journal of Nutrition"},{"issue":"2","key":"10.2903\/j.efsa.2024.8747_ref31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1095\/biolreprod34.2.322","article-title":"Age at puberty and first litter size in early and late paired rats","volume":"34","author":"Evans","year":"1986","journal-title":"Biology of Reproduction"},{"key":"10.2903\/j.efsa.2024.8747_ref32","unstructured":"FAO\/WHO . (2008). Joint FAO\/WHO Expert Committee on Food Additives. Sixty\u2010ninth meeting, Rome, Italy, 17\u201326 June 2008. Summary and conclusions. Issued 4 July 2008. Available at: https:\/\/www.fao.org\/documents\/card\/en\/c\/c1dfe308\u2010c04e\u2010444d\u20109885\u2010e2b20ef6bb07\/"},{"issue":"2","key":"10.2903\/j.efsa.2024.8747_ref33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/jps.23382","article-title":"Flavonoids and polymer derivatives as CYP3A4 inhibitors for improved oral drug bioavailability","volume":"102","author":"Fasinu","year":"2013","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.2903\/j.efsa.2024.8747_ref34","volume-title":"Improving the oral bioavailability of drugs through the design of modeled pre\u2010systemic cytochrome P450 inhibitors","author":"Fasinu","year":"2010"},{"key":"10.2903\/j.efsa.2024.8747_ref35","doi-asserted-by":"crossref","first-page":"G1148","DOI":"10.1152\/ajpgi.2000.279.6.G1148","article-title":"Bioavailability of the flavanone naringenin and its glycosides in rats. American journal of physiology","volume":"279","author":"Felgines","year":"2000","journal-title":"Gastrointestinal and Liver Physiology"},{"issue":"5","key":"10.2903\/j.efsa.2024.8747_ref36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1248\/bpb.20.560","article-title":"Grapefruit component interacting with rat and human P450 CYP3A: Possible involvement of non\u2010flavonoid components in drug interaction","volume":"20","author":"Fukuda","year":"1997","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.2903\/j.efsa.2024.8747_ref37","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1440-1681.2008.04987.x","article-title":"Modulatory effect of naringenin on N\u2010methyl\u2010N'\u2010nitro\u2010N\u2010nitrosoguanidine\u2010 and saturated sodium chloride\u2010induced gastric carcinogenesis in male Wistar rats","volume":"35","author":"Ganapathy","year":"2008","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"10.2903\/j.efsa.2024.8747_ref38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0007114507699358","article-title":"Flavanone plasma pharmacokinetics from blood orange juice in human subjects","volume":"98","author":"Gardana","year":"2007","journal-title":"British Journal of Nutrition"},{"issue":"2","key":"10.2903\/j.efsa.2024.8747_ref39","first-page":"129","article-title":"Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines","volume":"25","author":"Guo","year":"2004","journal-title":"Acta Pharmacologica Sinica"},{"issue":"3","key":"10.2903\/j.efsa.2024.8747_ref40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1517\/17425255.2011.553189","article-title":"The effect of grapefruit juice on drug disposition","volume":"7","author":"Hanley","year":"2011","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.2903\/j.efsa.2024.8747_ref41","doi-asserted-by":"crossref","unstructured":"Helle, J., Zierau, O., Kr\u00e4ker, K., Keiler, A., Vollmer, G., Welsh, J. E., & Kretzschmar, G. (2015). Estimation of safety\/risk profile of the phytoestrogens 8\u2010prenylnaringenin, 6\u2010(1.1\u2010 dimethylallyl)naringenin and naringenin in MCF\u20107 cells and the rat mammary gland. Experimental and Clinical Endocrinology & Diabetes, abstract, 122(3).","DOI":"10.1055\/s-0035-1547646"},{"key":"10.2903\/j.efsa.2024.8747_ref42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0031-6865(99)00062-X","article-title":"Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products","volume":"74","author":"Ho","year":"2000","journal-title":"Pharmaceutica Acta Helvetiae"},{"issue":"3","key":"10.2903\/j.efsa.2024.8747_ref43","first-page":"217","article-title":"Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds","volume":"4","author":"Ho","year":"2001","journal-title":"Journal of Pharmacy and Pharmaceutical Sciences"},{"key":"10.2903\/j.efsa.2024.8747_ref44","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0024-3205(01)01491-6","article-title":"Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits","volume":"70","author":"Hsiu","year":"2002","journal-title":"Life Sciences"},{"key":"10.2903\/j.efsa.2024.8747_ref45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.febslet.2009.11.026","article-title":"Structural activity relationship of flavonoids with estrogen\u2010related receptor gamma","volume":"584","author":"Huang","year":"2010","journal-title":"FEBS Letters"},{"key":"10.2903\/j.efsa.2024.8747_ref46","doi-asserted-by":"crossref","unstructured":"ICRP (International Commission on Radiological Protection) . (2002). Basic Anatomical and Physiological Data for Use in Radiological Protection Reference Values. ICRP Publication 89. Annals of the ICRP, volume 32, No. 3\u20134. https:\/\/doi.org\/10.1177\/ANIB_32_3\u20104","DOI":"10.1016\/S0146-6453(03)00002-2"},{"key":"10.2903\/j.efsa.2024.8747_ref47","unstructured":"JECFA (Joint FAO\/WHO Expert Committee on Food Additives) . (2022). Safety evaluation of certain food additives: prepared by the eighty\u2010ninth meeting of the Joint FAO\/WHO Expert Committee on Food Additives (JECFA). World Health Organization and Food and Agriculture Organization of the United Nations, Geneva (WHO Food Additives Series, No. 80)."},{"key":"10.2903\/j.efsa.2024.8747_ref48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/fstl.2000.0681","article-title":"Degradation of flavonoid glycosides and Aglycones during in\u00a0vitro fermentation with human Faecal Flora","volume":"33","author":"Justesen","year":"2000","journal-title":"LWT\u2010 Food Science and Technology"},{"key":"10.2903\/j.efsa.2024.8747_ref49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0021-9673(97)01061-3","article-title":"Quantitative analysis of flavonols, flavones, and flavanones in fruits, vegetables and beverages by high\u2010performance liquid chromatograph with photo\u2010diode array and mass spectrometric detection","volume":"A799","author":"Justesen","year":"1998","journal-title":"Journal of Chromatography"},{"key":"10.2903\/j.efsa.2024.8747_ref50","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/sj.ejcn.1602543","article-title":"Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects","volume":"61","author":"Kanaze","year":"2007","journal-title":"European Journal of Clinical Nutrition"},{"key":"10.2903\/j.efsa.2024.8747_ref51","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1021\/jf990153+","article-title":"Quantitation of flavonoid constituents in citrus fruits","volume":"47","author":"Kawaii","year":"1999","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"1, Suppl","key":"10.2903\/j.efsa.2024.8747_ref52","first-page":"636.2","article-title":"Accumulation of dietary naringenin and metabolites in mice","volume":"27","author":"Ke","year":"2013","journal-title":"The FASEB Journal"},{"issue":"4","key":"10.2903\/j.efsa.2024.8747_ref53","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/10717544.2013.878003","article-title":"Self\u2010nanoemulsifying drug delivery system (SNEDDS) of poorly water\u2010soluble grapefruit flavonoid Naringenin: Design, characterization, in\u00a0vitro and in\u00a0vivo evaluation","volume":"22","author":"Khan","year":"2015","journal-title":"Drug Delivery"},{"issue":"1","key":"10.2903\/j.efsa.2024.8747_ref54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF03216747","article-title":"Intestinal bacterial metabolism of flavonoids and its relation to some biological activities","volume":"21","author":"Kim","year":"1998","journal-title":"Archives of Pharmacal Research"},{"key":"10.2903\/j.efsa.2024.8747_ref55","first-page":"890","article-title":"Naringenin: A partial agonist on estrogen receptor in T47D\u2010KBluc breast cancer cells","volume":"6","author":"Kim","year":"2013","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"10.2903\/j.efsa.2024.8747_ref56","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/mnfr.200400022","article-title":"The pig caecum model: A suitable tool to study the intestinal metabolism of flavonoids","volume":"48","author":"Labib","year":"2004","journal-title":"Molecular Nutrition & Food Research"},{"key":"10.2903\/j.efsa.2024.8747_ref57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.fct.2014.01.023","article-title":"Six months chronic toxicological evaluation of naringin in Sprague\u2013Dawley rats","volume":"66","author":"Li","year":"2014","journal-title":"Food and Chemical Toxicology"},{"key":"10.2903\/j.efsa.2024.8747_ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2013.07.019","article-title":"Acute and 13\u2009weeks subchronic toxicological evaluation of naringin in Sprague\u2010Dawley rats","volume":"60","author":"Li","year":"2013","journal-title":"Food and Chemical Toxicology"},{"issue":"3","key":"10.2903\/j.efsa.2024.8747_ref59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7603\/s40681-014-0016-z","article-title":"Tissue distribution of naringenin conjugated metabolites following repeated dosing of naringin to rats","volume":"4","author":"Lin","year":"2014","journal-title":"Biomedicine (Taipei)"},{"issue":"10","key":"10.2903\/j.efsa.2024.8747_ref60","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/chir.21005","article-title":"Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms","volume":"23","author":"Lu","year":"2011","journal-title":"Chirality"},{"key":"10.2903\/j.efsa.2024.8747_ref61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.lwt.2019.03.059","article-title":"Effect of temperature, pH, \u03b2\u2010 and HP\u2010\u03b2\u2010cds on the solubility and stability of flavanones: Naringenin and hesperetin","volume":"108","author":"Lucas\u2010Abell\u00e1n","year":"2019","journal-title":"LWT"},{"key":"10.2903\/j.efsa.2024.8747_ref62","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijpharm.2005.10.018","article-title":"LC\/MS\/MS quantitation assay for pharmacokinetics of naringenin and double peaks phenomenon in rats plasma","volume":"307","author":"Ma","year":"2006","journal-title":"International Journal of Pharmaceutics"},{"key":"10.2903\/j.efsa.2024.8747_ref63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/bdrb.20208","article-title":"Inter\u2010laboratory control data for reproductive endpoints required in the OPPTS 870.3800\/OECD 416 reproduction and fertility test","volume":"86","author":"Marty","year":"2009","journal-title":"Birth Defects Research (Part B)"},{"issue":"3","key":"10.2903\/j.efsa.2024.8747_ref64","first-page":"1195","article-title":"Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice","volume":"261","author":"Miniscalco","year":"1992","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.2903\/j.efsa.2024.8747_ref65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s13105-013-0296-x","article-title":"Effect of simvastatin and naringenin coadministration on rat liver DNA fragmentation and cytochrome P450 activity: An in\u00a0vivo and in\u00a0vitro study","volume":"70","author":"Motawi","year":"2014","journal-title":"Journal of Physiology and Biochemistry"},{"key":"10.2903\/j.efsa.2024.8747_ref66","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Molecular Pharmaceutics"},{"key":"10.2903\/j.efsa.2024.8747_ref67","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/em.2860030402","article-title":"Mutagenicities of 61 flavonoids and 11 related compounds","volume":"3","author":"Nagao","year":"1981","journal-title":"Environmental Mutagenesis"},{"key":"10.2903\/j.efsa.2024.8747_ref68","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jn\/136.2.404","article-title":"Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: A randomized, double\u2010blind, crossover trial","volume":"136","author":"Nielsen","year":"2006","journal-title":"The Journal of Nutrition"},{"key":"10.2903\/j.efsa.2024.8747_ref69","unstructured":"OECD (Organisation for Economic Co\u2010operation and Development) . (1997). Test No. 471: Bacterial Reverse Mutation Test. OECD Guidelines for the Testing of Chemicals, Section\u00a04. https:\/\/doi.org\/10.1787\/9789264071247\u2010en"},{"key":"10.2903\/j.efsa.2024.8747_ref70","unstructured":"OECD (Organisation for Economic Co\u2010operation and Development) . (2016a). Test No. 487: In\u00a0Vitro Mammalian Cell Micronucleus Test. OECD Guidelines for the Testing of Chemicals, Section\u00a04. https:\/\/doi.org\/10.1787\/9789264264861\u2010en"},{"key":"10.2903\/j.efsa.2024.8747_ref71","unstructured":"OECD (Organisation for Economic Co\u2010operation and Development) . (2016b). Test No. 474: Mammalian Erythrocyte Micronucleus Test. OECD Guidelines for the Testing of Chemicals, Section\u00a04. https:\/\/doi.org\/10.1787\/9789264264762\u2010en"},{"key":"10.2903\/j.efsa.2024.8747_ref72","unstructured":"OECD (Organisation for Economic Co\u2010operation and Development) . (2016c). Test No. 489: In\u00a0Vivo Mammalian Alkaline Comet Assay. OECD Guidelines for the Testing of Chemicals, Section\u00a04. https:\/\/doi.org\/10.1787\/9789264264885\u2010en"},{"key":"10.2903\/j.efsa.2024.8747_ref73","unstructured":"OECD (Organisation for Economic Co\u2010operation and Development) . (2016d). Test No. 421: Reproduction\/Developmental Toxicity Screening Test. OECD Guidelines for the Testing of Chemicals, Section\u00a04. https:\/\/doi.org\/10.1787\/9789264264380\u2010en"},{"key":"10.2903\/j.efsa.2024.8747_ref74","unstructured":"OECD (Organisation for Economic Co\u2010operation and Development) . (2018a). Test No. 408: Repeated Dose 90\u2010DayOral Toxicity Study in Rodents (OECD TG), in Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption, OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/9789264304741\u2010en"},{"key":"10.2903\/j.efsa.2024.8747_ref75","unstructured":"OECD (Organisation for Economic Co\u2010operation and Development) . (2018b). Test No. 443: Extended One\u2010Generation Reproductive Toxicity Study. OECD Guidelines for the Testing of Chemicals, Section\u00a04. https:\/\/doi.org\/10.1787\/9789264185371\u2010en"},{"key":"10.2903\/j.efsa.2024.8747_ref76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1017\/S0007114515001671","article-title":"High gastrointestinal permeability and local metabolism of naringenin: Influence of antibiotic treatment on absorption and metabolism","volume":"114","author":"Orrego\u2010Lagar\u00f3n","year":"2015","journal-title":"British Journal of Nutrition"},{"key":"10.2903\/j.efsa.2024.8747_ref77","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpba.2015.10.040","article-title":"Metabolic profile of naringenin in the stomach and colon using liquid chromatography\/electrospray ionization linear ion trap quadrupole\u2010Orbitrap\u2010mass spectrometry (LC\u2010ESI\u2010LTQ\u2010Orbitrap\u2010MS) and LC\u2010ESI\u2010MS\/MS","volume":"120","author":"Orrego\u2010Lagar\u00f3n","year":"2016","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.2903\/j.efsa.2024.8747_ref78","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1463-1326.2008.00869.x","article-title":"Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra\u2010pancreatic glucose regulation","volume":"10","author":"Ortiz\u2010Andrade","year":"2008","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.2903\/j.efsa.2024.8747_ref79","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10715769900300161","article-title":"The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute?","volume":"30","author":"Paganga","year":"1999","journal-title":"Free Radical Research"},{"issue":"5","key":"10.2903\/j.efsa.2024.8747_ref80","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \"pie\"","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metabolism and Disposition"},{"issue":"3","key":"10.2903\/j.efsa.2024.8747_ref81","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mnfr.201400779","article-title":"In vitro colonic catabolism of orange juice (poly)phenols","volume":"59","author":"Pereira\u2010Caro","year":"2015","journal-title":"Molecular Nutrition & Food Research"},{"key":"10.2903\/j.efsa.2024.8747_ref82","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3945\/ajcn.114.090282","article-title":"Orange juice (poly)phenols are highly bioavailable in humans","volume":"100","author":"Pereira\u2010Caro","year":"2014","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.2903\/j.efsa.2024.8747_ref83","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00394-016-1312-z","article-title":"Catabolism of citrus flavanones by the probiotics Bifidobacterium longum and lactobacillus rhamnosus","volume":"57","author":"Pereira\u2010Caro","year":"2016","journal-title":"European Journal of Nutrition"},{"key":"10.2903\/j.efsa.2024.8747_ref84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.foodchem.2018.01.083","article-title":"Development and validation of an UHPLC\u2010HRMS protocol for the analysis of flavan\u20103\u2010ol metabolites and catabolites in urine, plasma and feces of rats fed a red wine proanthocyanidin extract","volume":"252","author":"Pereira\u2010Caro","year":"2018","journal-title":"Food Chemistry"},{"key":"10.2903\/j.efsa.2024.8747_ref85","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3109\/03639045.2015.1115868","article-title":"Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in wistar rats","volume":"42","author":"Pingili","year":"2016","journal-title":"Drug Development and Industrial Pharmacy"},{"issue":"1","key":"10.2903\/j.efsa.2024.8747_ref86","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/dom.13868","article-title":"Safety and pharmacokinetics of naringenin: A randomized, controlled, single\u2010ascending\u2010dose clinical trial","volume":"22","author":"Rebello","year":"2020","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"2","key":"10.2903\/j.efsa.2024.8747_ref87","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.freeradbiomed.2003.09.022","article-title":"Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products","volume":"36","author":"Rechner","year":"2004","journal-title":"Free Radical Biology and Medicine"},{"key":"10.2903\/j.efsa.2024.8747_ref88","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/0006-2952(95)02061-6","article-title":"Naringenin: A weakly estrogenic bioflavonoid that exhibits antiestrogenic activity","volume":"50","author":"Ruh","year":"1995","journal-title":"Biochemical Pharmacology"},{"key":"10.2903\/j.efsa.2024.8747_ref89","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0960-0760(01)00098-X","article-title":"No evidence for the in\u00a0vivo activity of aromatase\u2010inhibiting flavonoids","volume":"78","author":"Saarinen","year":"2001","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.2903\/j.efsa.2024.8747_ref90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002030050010","article-title":"Anaerobic degradation of flavonoids by Eubacterium ramulus","volume":"173","author":"Schneider","year":"2000","journal-title":"Archives of Microbiology"},{"issue":"10","key":"10.2903\/j.efsa.2024.8747_ref91","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1128\/AEM.69.10.5849-5854.2003","article-title":"Anaerobic degradation of flavonoids by clostridium orbiscindens","volume":"69","author":"Schoefer","year":"2003","journal-title":"Applied and Environmental Microbiology"},{"issue":"6","key":"10.2903\/j.efsa.2024.8747_ref92","first-page":"559","article-title":"Determination of LD50 of Naringenin for its effects on diabetic nephropathy in rats\u2010 a pilot study","volume":"7","author":"Selvam","year":"2015","journal-title":"Journal of Chemical and Pharmaceutical Research"},{"issue":"2","key":"10.2903\/j.efsa.2024.8747_ref93","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.foodchem.2009.05.002","article-title":"Development and validation of two new sensitive ELISAs for Hesperetin and Naringenin in biological fluids","volume":"118","author":"Shinkaruk","year":"2010","journal-title":"Food Chemistry"},{"key":"10.2903\/j.efsa.2024.8747_ref94","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jps.23357","article-title":"Major active components in grapefruit, orange, and apple juices responsible for OATP2B1\u2010mediated drug interactions","volume":"102","author":"Shirasaka","year":"2013","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.2903\/j.efsa.2024.8747_ref95","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2183\/pjab.53.194","article-title":"Mutagenicity of flavone derivatives","volume":"53B","author":"Sugimura","year":"1977","journal-title":"Proceedings of the Japan Academy. Series B, Physical and Biological Sciences"},{"issue":"10","key":"10.2903\/j.efsa.2024.8747_ref96","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3109\/03639045.2013.819885","article-title":"Enhanced oral bioavailability of felodipine by naringenin in Wistar rats and inhibition of P\u2010glycoprotein in everted rat gut sacs in\u00a0vitro","volume":"40","author":"Surya Sandeep","year":"2014","journal-title":"Drug Development and Industrial Pharmacy"},{"issue":"5","key":"10.2903\/j.efsa.2024.8747_ref97","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1476-5381.2011.01637.x","article-title":"A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts","volume":"165","author":"Swarnkar","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.2903\/j.efsa.2024.8747_ref98","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1248\/bpb.32.195","article-title":"Comparative study on the nuclear hormone receptor activity of various phytochemicals and their metabolites by reporter gene assays using Chinese hamster ovary cells","volume":"32","author":"Takeuchi","year":"2009","journal-title":"Biological and Pharmaceutical Bulletin"},{"issue":"8","key":"10.2903\/j.efsa.2024.8747_ref99","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/15216540400010792","article-title":"Mechanisms of naringenin\u2010induced apoptotic cascade in cancer cells: Involvement of estrogen receptor \u03b1 and \u03b2 signalling","volume":"56","author":"Totta","year":"2004","journal-title":"IUBMB Life"},{"issue":"13","key":"10.2903\/j.efsa.2024.8747_ref100","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0024-3205(99)00380-X","article-title":"In vitro inhibition of simvastatin metabolism in rat and human liver by naringenin","volume":"65","author":"Ubeaud","year":"1999","journal-title":"Life Sciences"},{"key":"10.2903\/j.efsa.2024.8747_ref101","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/chrsci\/49.4.316","article-title":"A stereospecific HPLC method and its application in determination of pharmacokinetics profile of two enantiomers of naringenin in rats","volume":"49","author":"Wan","year":"2011","journal-title":"Journal of Chromatographic Science"},{"issue":"3","key":"10.2903\/j.efsa.2024.8747_ref102","first-page":"247","article-title":"Pharmacokinetics and conjugation metabolism of Naringin and Naringenin in rats after single dose and multiple dose administrations","volume":"14","author":"Wang","year":"2006","journal-title":"Journal of Food and Drug Analysis"},{"key":"10.2903\/j.efsa.2024.8747_ref103","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/mutage\/gez011","article-title":"Inclusion of an extended treatment with recovery improves the results for the human peripheral blood lymphocyte micronucleus assay","volume":"34","author":"Whitwell","year":"2019","journal-title":"Mutagenesis"},{"key":"10.2903\/j.efsa.2024.8747_ref104","first-page":"63","article-title":"Pharmacokinetics of selected chiral flavonoids: Hesperetin, naringenin and eriodictyol in rats and their content in fruit juices","volume":"29","author":"Y\u00e1\u00f1ez","year":"2008","journal-title":"Free Radical Research"},{"key":"10.2903\/j.efsa.2024.8747_ref105","doi-asserted-by":"crossref","unstructured":"Yeo, E., Yew Chieng, C. J., Choudhury, H., Pandey, M., & Gorain, B. (2021). Tocotrienols\u2010rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in\u00a0vitro evaluations. Current Research in Pharmacolology and Drug Discovery, 2, 100019.","DOI":"10.1016\/j.crphar.2021.100019"},{"key":"10.2903\/j.efsa.2024.8747_ref106","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s13318-016-0380-z","article-title":"Identification of Naringin metabolites in human urine and feces","volume":"42","author":"Zeng","year":"2016","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.2903\/j.efsa.2024.8747_ref107","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/je4000718","article-title":"Solubility of Naringenin in ethanol and water mixtures","volume":"58","author":"Zhang","year":"2013","journal-title":"Journal of Chemical and Engineering Data"},{"key":"10.2903\/j.efsa.2024.8747_ref108","unstructured":"Zierau, O., Blei, T., Kretzschmar, G., Moeller, F. J., & Vollmer, G. (2012). In vivo anti\u2010androgenic activity of naringenin type phytoestrogens. Endocrine Reviews, 33(3, Suppl) [abstract SAT\u2010565]."},{"issue":"3","key":"10.2903\/j.efsa.2024.8747_ref109","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13318-014-0193-x","article-title":"Human intestinal microbial metabolism of naringin","volume":"40","author":"Zou","year":"2015","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"}],"container-title":["EFSA Journal"],"original-title":[],"link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.2903\/j.efsa.2024.8747","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.2903\/j.efsa.2024.8747\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T09:19:48Z","timestamp":1715764788000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.2903\/j.efsa.2024.8747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":109,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.2903\/j.efsa.2024.8747","relation":{},"ISSN":["1831-4732","1831-4732"],"issn-type":[{"value":"1831-4732","type":"print"},{"value":"1831-4732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}